| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Deborah M. Messemer is Director at ALLO, with reported holdings spanning 4 companies. Deborah M. Messemer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.6M at current prices.
Our model assigns Deborah M. Messemer a middling insider score of 63/100, based on 11 past trades. Over a 12-month horizon, 54.5% of those trades were profitable, with an average 12-month return of +9.9%.
Deborah M. Messemer's largest disclosed position is in PYPL as Director, worth about $1.2M. The PYPL filings lean toward selling, a net 8,217 shares.
Deborah M. Messemer has 32 Form 4 filings on record from October 2018 to July 2026, across 4 companies: Director at TPG Operating Group II, L.P. 6.950% Fixed-Rate Junior Subordinated Notes due 2064 (TPGXL), 2026; Director at Allogene Therapeutics (ALLO), 2018–2026; Director at PayPal (PYPL), 2019–2026, and 1 more.
The 35 reported transactions were 17 stock awards, 11 open-market sales, 6 option or other derivative awards and 1 other transaction.
Counted by filing, the open-market trades come to no purchases and 11 sales worth about $1.4M.
The largest open-market sale was 6,390 shares of TPG at an average $43.97 on February 28, 2024, about $281K. Twelve months later TPG was up 25%.
7 of the 11 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 4 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2025 | TPG Tpg Inc. | Director | Sell10b5-1 | 1,796 | $56.32 | $101,148.39 | -9.7% | +1.3% | -21.6% | |
| Jun 10, 2025 | ALLO Allogene Therapeutics, Inc. | Director | Sell10b5-1 | 36,885 | $1.42 | $52,376.70 | -25.6% | -21.9% | +21.9% | |
| Jun 6, 2025 | PYPL Paypal Holdings, Inc. | Director | Sell | 3,795 | $73.00 | $277,036.14 | -21.4% | -6.8% | -43.8% | |
| Feb 18, 2025 | ALLO Allogene Therapeutics, Inc. | Director | Sell10b5-1 | 13,313 | $2.43 | $32,350.59 | -8.4% | -61.6% | -20.1% | |
| Jan 14, 2025 | TPG Tpg Inc. | Director | Sell | 1,695 | $61.91 | $104,930.67 | -9.7% | -29.4% | +4.2% | |
| Dec 9, 2024 | ALLO Allogene Therapeutics, Inc. | Director | Sell10b5-1 | 9,136 | $2.18 | $19,916.48 | -5.5% | -9.7% | -37.4% | |
| Jul 17, 2024 | TPG Tpg Inc. | Director | Sell10b5-1 | 4,089 | $46.55 | $190,331.91 | -18.9% | +30.0% | +20.8% | |
| Jun 18, 2024 | ALLO Allogene Therapeutics, Inc. | Director | Sell10b5-1 | 18,641 | $2.28 | $42,488.43 | -10.1% | +23.8% | -42.2% | |
| May 24, 2024 | PYPL Paypal Holdings, Inc. | Director | Sell | 4,422 | $61.65 | $272,616.30 | -24.0% | +16.0% | +13.3% | |
| Feb 28, 2024 | TPG Tpg Inc. | Director | Sell | 6,390 | $43.97 | $280,980.44 | -26.2% | -0.9% | +25.0% |